UnitedHealth Group (UNH) Stock Forecast & Price Target

$500.13 +10.88 (+2.22%)

(As of 12/20/2024 05:45 PM ET)

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 22 Analyst Ratings

Sell
0

Hold
3

Buy
19

Based on 22 Wall Street analysts who have issued ratings for UnitedHealth Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 3 have given a hold rating, 17 have given a buy rating, and 2 have given a strong buy rating for UNH.

Consensus Price Target

$626.84
25.34% Upside

According to the 22 analysts' twelve-month price targets for UnitedHealth Group, the average price target is $626.84. The highest price target for UNH is $675.00, while the lowest price target for UNH is $559.00. The average price target represents a forecasted upside of 25.34% from the current price of $500.13.

Get the Latest News and Ratings for UNH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors.

UNH Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	17 Buy rating(s)	17 Buy rating(s)	18 Buy rating(s)	13 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$626.84	$615.53	$614.17	$574.89
Forecasted Upside	25.34% Upside	3.01% Upside	6.81% Upside	10.49% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Buy	Moderate Buy

Buy this coin BEFORE Inauguration Day … (Ad)

Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.

This could be his favorite coin.

UNH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

UNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

UnitedHealth Group Stock vs. The Competition

Type	UnitedHealth Group	Medical Companies	S&P 500
Consensus Rating Score	2.95	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	25.34% Upside	25,828.60% Upside	14.54% Upside
News Sentiment Rating	Neutral News See Recent UNH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/6/2024	Oppenheimer 3 of 5 stars		Boost Target	Outperform ➝ Outperform	$610.00 ➝ $640.00	+14.74%
12/5/2024	Stephens 4 of 5 stars		Boost Target	Overweight ➝ Overweight	$605.00 ➝ $675.00	+10.54%
12/3/2024	Deutsche Bank Aktiengesellschaft 3 of 5 stars		Boost Target	Buy ➝ Buy	$595.00 ➝ $625.00	+2.72%
11/27/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$603.00 ➝ $655.00	+7.63%
10/18/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$601.00 ➝ $609.00	+7.84%
10/17/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Herholdt Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
Get the Latest News and Ratings for UNH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors with MarketBeat's FREE daily newsletter.
10/17/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
10/16/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$680.00 ➝ $650.00	+13.16%
10/16/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$640.00 ➝ $625.00	+9.19%
10/16/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$591.00 ➝ $644.00	+12.51%
10/16/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$615.00 ➝ $595.00	+7.31%
10/16/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$675.00 ➝ $650.00	+17.23%
10/16/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$615.00 ➝ $610.00	+10.02%
10/11/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight ➝ Overweight	$675.00 ➝ $675.00	+12.94%
7/17/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Toung Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$570.00 ➝ $600.00	+4.95%
7/17/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$525.00 ➝ $630.00	+11.23%
7/17/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$597.00 ➝ $640.00	+16.60%
7/17/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$481.00 ➝ $647.00	+17.88%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/30/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$546.00 ➝ $559.00	+15.75%
4/17/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$566.00 ➝ $571.00	+18.76%
3/13/2024	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
7/18/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$595.00 ➝ $603.00	+24.55%
7/11/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$600.00 ➝ $549.00	+18.56%
6/14/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$625.00 ➝ $560.00	+13.98%
4/17/2023	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$590.00 ➝ $600.00	+17.24%
4/14/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Strong-Buy	$630.00	+24.75%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:52 AM ET.

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, December 15, 2024. Please send any questions or comments about these UnitedHealth Group pros and cons to contact@marketbeat.com.

UnitedHealth Group
Bull Case

Here are some ways that investors could benefit from investing in UnitedHealth Group:

Strong Earnings Performance: UnitedHealth Group recently reported earnings per share of $7.15, exceeding analysts' expectations of $7.00, indicating robust financial health and effective management.
Consistent Revenue Growth: The company achieved a revenue of $100.82 billion for the latest quarter, surpassing estimates and reflecting a year-over-year growth of 9.2%, showcasing its ability to expand in the competitive healthcare market.
Attractive Dividend Yield: UnitedHealth Group declared a quarterly dividend of $2.10, translating to an annualized yield of 1.60%. This consistent dividend payment can provide a steady income stream for investors.
High Return on Equity: With a return on equity of 26.37%, UnitedHealth Group demonstrates effective use of shareholders' equity to generate profits, which is a positive indicator for potential investors.
Current Stock Price: As of the latest trading session, UnitedHealth Group's stock price is $515.73, which may present a buying opportunity for investors looking to enter at a lower price point compared to its 52-week high of $630.73.

UnitedHealth Group
Bear Case

Investors should be bearish about investing in UnitedHealth Group for these reasons:

Recent Stock Decline: The stock has experienced a decline of 3.3% recently, which may indicate market volatility or investor concerns about future performance.
High Debt-to-Equity Ratio: With a debt-to-equity ratio of 0.74, the company has a significant amount of debt compared to its equity, which could pose risks if interest rates rise or if the company faces financial challenges.
Market Competition: The healthcare sector is highly competitive, and UnitedHealth Group faces challenges from other major players, which could impact its market share and profitability.
Analyst Target Price Adjustments: Recent adjustments in target prices by analysts, such as Royal Bank of Canada lowering its target from $615.00 to $595.00, may reflect concerns about the stock's future performance.
Dividend Payout Ratio: The company's dividend payout ratio stands at 54.72%, which, while sustainable, indicates that a significant portion of earnings is being distributed as dividends, potentially limiting reinvestment in growth opportunities.

UNH Forecast - Frequently Asked Questions

: According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for UnitedHealth Group is $626.84, with a high forecast of $675.00 and a low forecast of $559.00.
: 22 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last year. There are currently 3 hold ratings, 17 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" UNH shares.
: According to analysts, UnitedHealth Group's stock has a predicted upside of 25.34% based on their 12-month stock forecasts.
: Over the previous 90 days, UnitedHealth Group's stock had 2 downgrades and 1 upgrade by analysts.
: UnitedHealth Group has been rated by research analysts at Bank of America, Barclays, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Hsbc Global Res, HSBC, KeyCorp, Morgan Stanley, Oppenheimer, Royal Bank of Canada, Stephens, TD Cowen, Truist Financial, and UBS Group in the past 90 days.
: Analysts like UnitedHealth Group more than other "medical" companies. The consensus rating score for UnitedHealth Group is 2.95 while the average consensus rating score for "medical" companies is 2.81. Learn more on how UNH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

This page (NYSE:UNH) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UnitedHealth Group (UNH) Stock Forecast & Price Target